Alejandro Nicolas Aguzin bought $972k of GLOB
director at Globant S.A.. 25,000 shares at an average of $38.87, traded May 27, 2026, filed May 28, 2026.
Score components
- +15RoleDirector
- +25Trade size$972k at market
- +10Relative to holdingsHoldings up 108%
- +8Price context62% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-26-038711, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 27, 2026 | POpen-market purchase Common Stock | +25,000 | $38.87 | $972k | 48,158 | May 28, 2026 |
Related signals
Other insiders at Globant S.A. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | Globant S.A. | Fernando Matzkin Chief Revenue Officer | $100k 2,500 shares | -3% | |
| 43Moderate | Globant S.A. | Wanda Weigert Chief Brand Officer | $243k 6,000 shares | -9% | |
| 43Moderate | Globant S.A. | Diego Tartara Chief Technology Officer | $243k 6,000 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.